BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Canadian Rare Disease Network - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Canadian Rare Disease Network
X-ORIGINAL-URL:https://canadianrdn.ca
X-WR-CALDESC:Events for Canadian Rare Disease Network
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Dubai
BEGIN:STANDARD
TZOFFSETFROM:+0400
TZOFFSETTO:+0400
TZNAME:+04
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20240604T140000
DTEND;TZID=Asia/Dubai:20240604T150000
DTSTAMP:20260411T160512
CREATED:20240530T011323Z
LAST-MODIFIED:20240531T211918Z
UID:4304-1717509600-1717513200@canadianrdn.ca
SUMMARY:FcRn Inhibitors and Novel Options for Myasthenia Gravis
DESCRIPTION:Muscular Dystrophy Canada (MDC) is pleased to present a webinar on the neonatal Fc receptor (FcRn) pathway for people with generalized Myasthenia Gravis (gMG). MDC is excited to have their webinar speaker discuss next generation treatments for Myasthenia Gravis and help us understand how these treatments work in the neuromuscular pathway.
URL:https://canadianrdn.ca/event/fnrn-inhibitors-and-novel-options-for-myasthenia-gravis/
CATEGORIES:Provincial,Virtual,Webinars
END:VEVENT
END:VCALENDAR